| Literature DB >> 29203584 |
M Edward Quach1, Matthew A Dragovich2, Wenchun Chen1, Anum K Syed1, Wenpeng Cao2, Xin Liang1, Wei Deng1, Simon F De Meyer3, Guangheng Zhu4, Jun Peng5, Heyu Ni4, Carolyn M Bennett1, Ming Hou5, Jerry Ware6, Hans Deckmyn3, X Frank Zhang2, Renhao Li1.
Abstract
Immune thrombocytopenia (ITP) is a prevalent autoimmune disease characterized by autoantibody-induced platelet clearance. Some ITP patients are refractory to standard immunosuppressive treatments such as intravenous immunoglobulin (IVIg). These patients often have autoantibodies that target the ligand-binding domain (LBD) of glycoprotein Ibα (GPIbα), a major subunit of the platelet mechanoreceptor complex GPIb-IX. However, the molecular mechanism of this Fc-independent platelet clearance is not clear. Here, we report that many anti-LBD monoclonal antibodies such as 6B4, but not AK2, activated GPIb-IX in a shear-dependent manner and induced IVIg-resistant platelet clearance in mice. Single-molecule optical tweezer measurements of antibodies pulling on full-length GPIb-IX demonstrated that the unbinding force needed to dissociate 6B4 from the LBD far exceeds the force required to unfold the juxtamembrane mechanosensory domain (MSD) in GPIbα, unlike the AK2-LBD unbinding force. Binding of 6B4, not AK2, induced shear-dependent unfolding of the MSD on the platelet, as evidenced by increased exposure of a linear sequence therein. Imaging flow cytometry and aggregometry measurements of platelets and LBD-coated platelet-mimetic beads revealed that 6B4 can sustain crosslinking of platelets under shear, whereas 6B4 Fab and AK2 cannot. These results suggest a novel mechanism by which anti-LBD antibodies can exert a pulling force on GPIb-IX via platelet crosslinking, activating GPIb-IX by unfolding its MSD and inducing Fc-independent platelet clearance.Entities:
Mesh:
Substances:
Year: 2017 PMID: 29203584 PMCID: PMC5814932 DOI: 10.1182/blood-2017-05-784975
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113